Health Care [ 8/12 ] | Health Care Equipment & Supplies [ 35/74 ]
NYSE | Common Stock
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally.
The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.
In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines.
Furthermore, the company provides medical technologies.
It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets.
Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016.
The company was founded in 1970 and is headquartered in Plano, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 13, 25 | 1.43 Increased by +2.88% | 1.46 Decreased by -1.97% |
| Oct 24, 24 | 1.43 Increased by +12.60% | 1.36 Increased by +5.15% |
| Jul 25, 24 | 1.30 Increased by +14.04% | 1.25 Increased by +4.00% |
| Apr 25, 24 | 1.14 Increased by +31.03% | 1.11 Increased by +2.70% |
| Feb 15, 24 | 1.39 Increased by +25.23% | 1.33 Increased by +4.51% |
| Oct 26, 23 | 1.27 Increased by +33.68% | 1.10 Increased by +15.45% |
| Jul 27, 23 | 1.14 Increased by +9.62% | 1.00 Increased by +14.00% |
| Apr 27, 23 | 0.87 Increased by +11.54% | 0.83 Increased by +4.82% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 449.50 M Increased by +8.80% | 32.70 M Increased by +24.08% | Increased by +7.28% Increased by +14.04% |
| Sep 30, 24 | 431.42 M Increased by +6.60% | 35.44 M Increased by +30.02% | Increased by +8.21% Increased by +21.96% |
| Jun 30, 24 | 436.57 M Increased by +9.13% | 31.25 M Increased by +30.35% | Increased by +7.16% Increased by +19.44% |
| Mar 31, 24 | 414.80 M Increased by +9.51% | 20.51 M Increased by +56.97% | Increased by +4.94% Increased by +43.34% |
| Dec 31, 23 | 413.15 M Increased by +10.94% | 26.36 M Increased by +45.48% | Increased by +6.38% Increased by +31.14% |
| Sep 30, 23 | 404.69 M Increased by +18.10% | 27.26 M Increased by +69.75% | Increased by +6.74% Increased by +43.74% |
| Jun 30, 23 | 400.04 M Increased by +14.27% | 23.97 M Increased by +15.05% | Increased by +5.99% Increased by +0.68% |
| Mar 31, 23 | 378.79 M Increased by +21.83% | 13.06 M Increased by +14.94% | Increased by +3.45% Decreased by -5.66% |